[1] OLSEN E A, MESSENGER A G, SHAPIRO J, et al. Evaluation and treatment of male and female pattern hair loss[J]. J Am Acad Dermato, 2005, 52(2):301-311. [2] GHANAAT M. Types of hair loss and treatment options, includ-ing the novel low-level light therapy and its proposed mechanism[J]. South Med J, 2010, 103(9):917-921. [3] MESTER E, SZENDE B, GÄRTNER P. The effect of laser beams on the growth of hair in mice[J]. Radiobiol Radiother , 1968, 9(5):621-626. [4] CHUNG P S, KIM Y C, CHUNG M S,et al. The effect of low-power laser on the murine hair growth[J]. Korean Soc Plastic Reconstruct Surg, 2004(31):1-8. [5] YU H S, WU C S, YU C L, et al. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental vitiligo [J]. J Invest Dermatol, 2003, 120(1):56-64. [6] CONLAN M J, RAPLEY J W, COBB C M, et al. Biostimulation of wound healing by low-energy laser irradiation[J]. J Clin Periodontol, 1996, 23(5):492-496. [7] GHANAAT M. Types of hair loss and treatment options, includ- ing the novel low-level light therapy and its proposed mechanism[J]. South Med J, 2010, 103(9):917-921. [8] WILLEY A, TORRONTEGUI J, AZPIAZU J, et al. Hair stimulation following laser and intense pulsed light photo-epilation:review of 543 cases and ways to manage it[J]. Lasers Surg Med, 2007, 39(4):297-301. [9] KIM H,CHOI J W,KIM J Y, et al. Low-level light therapy for androgenetic alopecia: a 24-week,randomized,double-blind,sham device-controlled multicenter trial[J]. Dermatol Surg, 2013, 39(8): 1177-1183. [10] LADAN AFIFI, MARANDA E L, MINA ZAREI, et al. Low-level laser therapy as a treatment for androgenetic alopecia[J]. Lasers Surg Med, 2016, 49(1):27-39. [11] LEAVITT M, CHARLES G, HEYMAN E, et al. HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trial[J]. Clin Drug Investig, 2009, 29(5): 283-292. [12] JIMENEZ J J, WIKRAMANAYAKE T C, BERGFELD W, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: A multicenter, randomized, sham device-controlled, double-blind study[J]. Am J Clin Dermatol, 2014, 15(2):115-127. [13] AVRAM M R, ROGERS N E. The use of low-level light for hair growth: Part I[J]. J Cutan Laser Ther, 2009, 11(2):110-117. [14] MATOS B N, MELO L M A, PEREIRA M N, et al. Iontophoresis on minoxidil sulphate-loaded chitosan nanoparticles accelerates drug release, decreasing their targeting effect to hair follicles[J]. Quim Nova, 2017, 40(2):154-157. [15] OLSEN E A, WHITING D, BERGFELD W, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men[J]. J Am Acad Dermatol, 2007, 57(5):767-774. [16] TAKEUCHI I, HIDA Y, MAKINO K. Minoxidil-encapsulated poly(L-lactide-co-glycolide) nanoparticles with hair follicle delivery properties prepared using W/O/W solvent evaporation and sonication[J]. Bio Medical Materials and Engineering, 2018, 29(2):217-228. [17] CAMACHO F M, GARCIA-HERNANDEZ M J, FERNANDEZ-CREHUET J L. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old[J]. Br J Dermatol, 2008, 158(5):1121-1124. [18] 刘艳, 马晓蕾, 周城, 等. 雄激素性秃发790例随访分析[J]. 临床皮肤科杂志, 2011, 40(6):343-345. [19] WON Y Y, LEW B L, SIM W Y. Clinical efficacy of oral administration of finasteride at a dose of 2.5 mg/day in women with female pattern hair loss[J]. Dermatol Ther, 2018, 2(20):112-118. [20] JUAN FERRANDO, SANDRA CECILIA, GONZáLEZ-de-COSSíO AC, et al. A Proposal of an Effective Platelet-rich Plasma Protocol for the Treatment of Androgenetic Alopecia[J]. Inter J Trichol,2017, 9(4):165-170. [21] DHURAT R, SUKESH M, AVHAD G, et al. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study[J]. Inter J Trichol, 2013, 5(1):6-11. [22] BOERSMA I H, ORANJE A P, GRIMALT R, et al. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia[J]. Indian J Dermatol Venereol Leprol, 2014, 80(6):521-525. [23] SHANSHANWAL S J S, DHURAT R S. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study[J]. Indian J Dermatol Venereol Leprol, 2017, 83(1):47-54. [24] REID E E, HALEY A C, JH BOROVICKA, et al. Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia[J]. J Am Acad Dermatol, 2012, 66(3):97-102. [25] WELLS P A, WILLMOTH T, RUSSELL R J. Does fortune favour the bald? Psychological correlates of hair loss in males[J]. Bri J Psychol, 1995, 86(3):337-344. |